论文部分内容阅读
BACKGROUND Recent studies have revealed the endocannabinoid system as a potential therapeutic target in the management of nonalcoholic fatty liver disease(NAFLD).Cannabis use is associated with reduced risk for NAFLD,we hypothesized that cannabis use woul